FDA approves mRNA flu vaccine for adults 50 and older
The U.S. Food and Drug Administration has approved the nation's first messenger RNA-based seasonal influenza vaccine for adults aged 50 and older.
The Daily Verified Briefing
Recent verified news about Stéphane Bancel, CEO & Director at Moderna, Inc..
The U.S. Food and Drug Administration has approved the nation's first messenger RNA-based seasonal influenza vaccine for adults aged 50 and older.